Bikdeli, B., Ujueta, F., Rashedi, S., Talasaz, A. H., Kadakia, K. T., Lopes, R. D., … Krumholz, H. M. (2025). Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations. J Am Coll Cardiol, 85(22), 2074–2078. https://doi.org/10.1016/j.jacc.2025.04.002

Bikdeli, Behnood, Francisco Ujueta, Sina Rashedi, Azita H. Talasaz, Kushal T. Kadakia, Renato D. Lopes, Harvey D. White, et al. “Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations.” J Am Coll Cardiol 85, no. 22 (June 10, 2025): 2074–78. https://doi.org/10.1016/j.jacc.2025.04.002.

Bikdeli B, Ujueta F, Rashedi S, Talasaz AH, Kadakia KT, Lopes RD, et al. Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations. J Am Coll Cardiol. 2025 Jun 10;85(22):2074–8.

Bikdeli, Behnood, et al. “Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations.” J Am Coll Cardiol, vol. 85, no. 22, June 2025, pp. 2074–78. Pubmed, doi:10.1016/j.jacc.2025.04.002.

Bikdeli B, Ujueta F, Rashedi S, Talasaz AH, Kadakia KT, Lopes RD, White HD, Steg PG, Piazza G, Al-Lamee RK, Cohen DJ, Mehran R, Krumholz HM. Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations. J Am Coll Cardiol. 2025 Jun 10;85(22):2074–2078.